Macrophage activation by a vanadyl–aspirin complex is dependent on L-type calcium channel and the generation of nitric oxide
Authors:
- Ana María CortizoACAna María Cortizo
- 1 June 2005
- journal article
- Published by Elsevier in Toxicology
- Vol. 210 (2-3) , 205-212
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Modulation of Cav1 and Cav2.2 channels induced by nitric oxide via cGMP-dependent protein kinaseNeurochemistry International, 2004
- Vanadium in cancer treatmentCritical Reviews in Oncology/Hematology, 2002
- A vanadium/aspirin complex controlled release using a poly(β - propiolactone) film. Effects on osteosarcoma cellsJournal of Biomaterials Science, Polymer Edition, 2001
- Vanadyl Ion Suppresses Nitric Oxide Production from Peritoneal Macrophages of Streptozotocin-Induced Diabetic MiceBiochemical and Biophysical Research Communications, 1996
- One‐year Treatment of Streptozotocin‐Induced Diabetic Rats with Vanadyl SulphateBasic & Clinical Pharmacology & Toxicology, 1994
- Peroxynitrite-mediated oxidation of dihydrorhodamine 123Free Radical Biology and Medicine, 1994
- Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV)Canadian Journal of Physiology and Pharmacology, 1993
- Vanadium salts and the future treatment of diabetesEndeavour, 1993
- Mechanisms of Action of VanadiumAnnual Review of Pharmacology and Toxicology, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970